ArticleFrontiers in oncology2021

Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.

Zhixian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.